drugset / Trial / NCT07596485

RP-008 in Combination With Daily Oral Varenicline for the Treatment of Trigeminal Neuralgia

NCT07596485

Phase 1/2 Recruiting 24 enrolled Kriya Therapeutics, Inc.
NaSequentialOpen-labelTreatment

Summary

The goal of this study is to evaluate if KRIYA-748 (RP-008) is safe, tolerable, and preliminary effective in treating trigeminal neuralgia (TN) when used in combination with varenicline tartrate. The study will also assess what doses of RP-008 are safe and tolerable for participants and how the severity of participants' TN pain and frequency of facial pain attacks are affected.

Timeline

Start
2026-08
Primary completion
2029-02
Completion
2029-02

Drugs

EvaluationDrugModalityDoseRoute
Subject RP-008 Unknown Other
Background Varenicline Small molecule Oral

Indications